Compatibility Assessment Of A Model Monoclonal Antibody Formulation In Glass And Blow/ Fill/Seal (BFS) Plastic Vial

Summary:  To address the potential compatibility concerns with Blow/Fill/Seal (BFS) processed container systems for biologics, experts at Catalent Pharma conducted a comprehensive study. The study evaluated the influence of BFS process and container system on a model monoclonal antibody formulation. It confirms compatibility of the model monoclonal antibody formulation in the advanced BFS container system and demonstrates comparability to traditional glass vials. 

Click here to download the technical note.